Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California.
Drug Metab Dispos. 2013 Nov;41(11):1923-33. doi: 10.1124/dmd.113.053223. Epub 2013 Aug 23.
Mefenamic acid (MFA), a carboxylic acid-containing nonsteroidal anti-inflammatory drug, is metabolized into the chemically-reactive MFA-1-O-acyl-glucuronide (MFA-1-O-G), MFA-acyl-adenylate (MFA-AMP), and the MFA-S-acyl-coenzyme A (MFA-CoA), all of which are electrophilic and capable of acylating nucleophilic sites on biomolecules. In this study, we investigate the nonenzymatic ability of each MFA acyl-linked metabolite to transacylate amino and thiol functional groups on the acceptor biomolecules Gly, Tau, l-glutathione (GSH), and N-acetylcysteine (NAC). In vitro incubations with each of the MFA acyl-linked metabolites (1 μM) in buffer under physiologic conditions with Gly, Tau, GSH, or NAC (10 mM) revealed that MFA-CoA was 11.5- and 19.5-fold more reactive than MFA-AMP toward the acylation of cysteine-sulfhydryl groups of GSH and NAC, respectively. However, MFA-AMP was more reactive toward both Gly and Tau, 17.5-fold more reactive toward the N-acyl-amidation of taurine than its corresponding CoA thioester, while MFA-CoA displayed little reactivity toward glycine. Additionally, mefenamic acid-S-acyl-glutathione (MFA-GSH) was 5.6- and 108-fold more reactive toward NAC than MFA-CoA and MFA-AMP, respectively. In comparison with MFA-AMP and MFA-CoA, MFA-1-O-G was not significantly reactive toward all four bionucleophiles. MFA-AMP, MFA-CoA, MFA-1-O-G, MFA-GSH, and mefenamic acid-taurine were also detected in rat in vitro hepatocyte MFA (100 μM) incubations, while mefenamic acid-glycine was not. These results demonstrate that MFA-AMP selectively reacts with the amino functional groups of glycine and lysine nonenzymatically, MFA-CoA selectively reacts nonenzymatically with the thiol functional groups of GSH and NAC, and MFA-GSH reacts with the thiol functional group of GSH nonenzymatically, all of which may potentially elicit an idiosyncratic toxicity in vivo.
甲芬那酸(MFA)是一种含羧酸的非甾体抗炎药,可代谢为化学活性的 MFA-1-O-酰基葡萄糖醛酸(MFA-1-O-G)、MFA-酰基腺苷酸(MFA-AMP)和 MFA-S-酰基辅酶 A(MFA-CoA),这些物质均具有亲电性,能够酰化生物分子上的亲核性位点。在这项研究中,我们研究了每种 MFA 酰基连接代谢物的非酶促能力,以转酰化受体生物分子甘氨酸、牛磺酸、l-谷胱甘肽(GSH)和 N-乙酰半胱氨酸(NAC)上的氨基和硫醇官能团。在生理条件下,将每种 MFA 酰基连接代谢物(1 μM)与甘氨酸、牛磺酸、GSH 或 NAC(10 mM)在缓冲液中进行体外孵育,结果表明,MFA-CoA 对 GSH 和 NAC 中半胱氨酸巯基的酰化反应性分别比 MFA-AMP 高 11.5 倍和 19.5 倍。然而,MFA-AMP 对甘氨酸和牛磺酸的反应性更强,对牛磺酸的 N-酰基酰胺化反应性比相应的 CoA 硫酯高 17.5 倍,而 MFA-CoA 对甘氨酸的反应性则较低。此外,甲芬那酸-S-酰基谷胱甘肽(MFA-GSH)对 NAC 的反应性比 MFA-CoA 和 MFA-AMP 分别高 5.6 倍和 108 倍。与 MFA-AMP 和 MFA-CoA 相比,MFA-1-O-G 对所有四种生物亲核试剂均无明显反应性。在大鼠体外肝细胞 MFA(100 μM)孵育中也检测到 MFA-AMP、MFA-CoA、MFA-1-O-G、MFA-GSH 和甲芬那酸-牛磺酸,而未检测到甲芬那酸-甘氨酸。这些结果表明,MFA-AMP 选择性地与甘氨酸和赖氨酸的氨基功能基团非酶促反应,MFA-CoA 选择性地与 GSH 和 NAC 的巯基功能基团非酶促反应,而 MFA-GSH 则与 GSH 的巯基功能基团非酶促反应,所有这些都可能在体内引发特发性毒性。